chevron_leftBack
As of 5 June 2026, Sanofi India Ltd. has a market cap of $826.1M USD, ranking #11872 globally and #641 in India.
It ranks #1083 in the Healthcare sector, and #404 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$826.1MUSD
79.1B INR
Enterprise Value
$800.5MUSD
76.65B INR
Revenue (TTM)
$185.37MUSD
17.75B INR
EBITDA (TTM)
$47.93MUSD
4.59B INR
Net Income (TTM)
$32.35MUSD
3.1B INR
EBITDA Margin
26%
Profit Margin
17%
PE Ratio
25.5
Forward PE
19.5
PS Ratio
4.5
PB Ratio
10.6
EV/EBITDA
16.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Deepak Arora
open_in_new
Employees
1,097
Founded
1956
Website
sanofi.com/en/india/investors
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.8% | -1.9% | 7.6% | -16% | -28% | -43% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
SANOFI
Sanofi India Ltd
ISIN: INE058A01010
Shares Out.:
Shares Outstanding:
23.03M1
Shares Float:
8.482M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
3,407.20 INR | |
|
500674
(SANOFI)
Sanofi India Ltd
ISIN: INE058A01010
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
3,434.55 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Sanofi India Ltd.
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, epilepsy, anti-infectives, and central nervous system, as well as allergy, pain care, digestive, and nutritional health under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors. It also exports its products to approximately 24 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: SUNPHARMA
|
$44.57B
5K%
4.27T INR
|
39.1
|
|
NSE: DIVISLAB
|
$18.12B
2K%
1.73T INR
|
70.0
|
|
NSE: TORNTPHARM
|
$14.95B
2K%
1.43T INR
|
63.0
|
|
NSE: DRREDDY
|
$11.57B
1K%
1.11T INR
|
19.6
|
|
NSE: MANKIND
|
$9.73B
1K%
931.67B INR
|
52.2
|
|
NSE: ZYDUSLIFE
|
$9.57B
1K%
916.53B INR
|
18.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
92K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
66K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
44K%
|
97.4
|
|
SIX: RO
|
$324.68B
39K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.43B
35K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$277.35B
33K%
218.9B CHF
|
20.5
|
chevron_leftBack